Hadas Nicole R.
SEC CIK 1602396 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | SVP, CLO | 651.2K | — | $175.4K | 11 | 2022-02-28 | 2024-05-13 |
Most active insiders at AKBA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Butler John P. | CEO, Pres, Dir | $86.6K | $474.4K |
| 2 | Grund Nicholas | Chief Commercial Off | — | $117.9K |
| 3 | Ostrowski Erik | SVP, CFO, CBO, Treas | — | $110.8K |
| 4 | Rucci Carolyn M. | SVP, CLO | — | $97.0K |
| 5 | Burke Steven Keith | SVP, Chief Medical Off | — | $94.0K |
| 6 | Malabre Richard C | SVP, CAO | — | $68.8K |
| 7 | FRIESON RON | Dir | — | — |
| 8 | Wolf Myles | Dir | — | — |
| 9 | Smith Cynthia | Dir | — | — |
| 10 | ADAMS ADRIAN | Dir | — | — |
Hadas Nicole R. made no open-market trades at AKBA in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-05-14 | 2024-05-13 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | S - Sale | $1.26 | -12.0K | 651.2K | -2% | -$15.1K |
| 2024-03-01 | 2024-02-29 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | S - Sale | $1.58 | -5,974 | 663.3K | -0.9% | -$9,439 | |
| T | 2024-02-29 | 2024-02-27 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | S - Sale | $1.52 | -7,411 | 669.2K | -1% | -$11.3K |
| D | 2024-02-02 | 2024-01-31 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | A - Grant | $0.00 | +149.3K | 676.6K | +28% | $0 |
| D | 2023-05-25 | 2023-05-24 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | A - Grant | $0.00 | +200.0K | 587.5K | +52% | $0 |
| D | 2023-05-25 | 2023-05-25 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | S - Sale | $1.22 | -63.2K | 524.3K | -11% | -$77.1K |
| 2023-05-16 | 2023-05-12 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | A - Grant | $0.00 | +100.0K | 387.5K | +35% | $0 | |
| M | 2023-03-03 | 2023-03-01 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | S - Sale | $0.88 | -13.0K | 295.2K | -4% | -$11.5K |
| 2023-03-01 | 2023-02-27 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | S - Sale | $0.81 | -6,677 | 300.6K | -2% | -$5,408 | |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | S - Sale | $2.16 | -21.1K | 308.9K | -6% | -$45.6K |
| D | 2022-03-02 | 2022-02-28 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO | A - Grant | $0.00 | +50.0K | 315.7K | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations